The mechanism by which GLP-1 receptor agonists might contribute to pancreatitis risk remains unclear, but possibilities include effects on pancreatic enzyme secretion, changes in gallbladder motility leading to gallstone formation, or direct effects on pancreatic tissue
Although preclinical studies have elucidated the mechanisms by which drugs can treat gout through modulation of BA metabolism, their efficacy still requires validation in large-scale clinical trials
Surprisingly, no associations were found between GLP-1 receptor agonists and breast cancer risk. People prescribed GLP-1s had a higher risk for kidney cancer compared with those receiving metformin (HR = 1.54
Risks are compounded by injection by people with little or no experience with the injection of drugs, and any information provided by people with no expertise or qualifications to provide such information, leading to dangerous injection practices. Injection site injuries (including damage caused by the product/drug) are commonly the result of the use of inappropriate injecting equipment for the application, e.g., a needle of inappropriate gauge or length for the intended injection site and depth
Some women see steady weight loss
GHK-Cus strongest data are topical and cosmetic
